Market Overview

ARATANA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aratana Therapeutics - PETX

Share:

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the
law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the
proposed sale of Aratana Therapeutics (NasdaqGM: PETX) ("Aratana") to
Elanco Animal Health (NYSE:ELAN) ("Elanco"). Under the terms of the
proposed transaction, shareholders of Aratana will receive only 0.1481
shares of Elanco and one contingent value right valued at $0.25 for each
share of Aratana that they own. KSF is seeking to determine whether this
consideration and the process that led to it are adequate, or whether
the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if
you would like to discuss your legal rights regarding the proposed sale,
you may, without obligation or cost to you, e-mail or call KSF Managing
Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com)
toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgm-petx/
to learn more.

To learn more about KSF, whose partners include the Former Louisiana
Attorney General, visit www.ksfcounsel.com.

View Comments and Join the Discussion!
 
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com